News|Articles|August 23, 2013
Skyepharma Names CFO and Executive Director
Author(s)Pharmaceutical Technology Editors
Andrew Derodra will join Skyepharma in the fourth quarter of 2013.
Advertisement
The drug-delivery company
Derodra joins Skyepharma from Tate & Lyle, where he had been group vice-president, finance and control, since 2011. He has spent 23 years working in senior finance roles for various companies, including SABMiller, Diageo, British Airways, and Reed Elsevier.
Source:
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
De-risking Biologic Development: Engineering Flexibility from Early Development to Launch
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
4
Behind the Headlines Episode 30: 2026 Wish List
5